Malady Kyle 4
4 · VERIZON COMMUNICATIONS INC · Filed Apr 10, 2026
Research Summary
AI-generated summary of this filing
Verizon (VZ) EVP Malady Kyle Receives Phantom Stock Award
What Happened Malady Kyle, EVP and Group CEO–VZ Business at Verizon (VZ), was granted 127.53 units of phantom stock on 2026-04-09. The grant is recorded at $13.63 per unit for a notional value of approximately $1,738. This transaction is an award/acquisition (code A) of a derivative compensation instrument (phantom stock), not an open‑market purchase of common shares.
Key Details
- Transaction date: 2026-04-09; Filing date (Form 4): 2026-04-10.
- Amount: 127.53 phantom stock units at $13.63 per unit; total notional value ≈ $1,738.
- Shares owned after transaction: not specified in the filing.
- Footnotes:
- F1 — Each phantom share is the economic equivalent of a portion of one common share and is settled in cash; payout occurs under events elected under the deferred compensation plan.
- F2 — Includes phantom stock acquired via dividend reinvestment.
- Transaction type: derivative award (phantom stock), code A.
Context Phantom stock is a form of deferred, cash‑settled compensation and does not represent immediate ownership of Verizon common stock or an open‑market bet on the company. Such awards are routine for executive compensation and should be interpreted as compensation-related, not necessarily as a buying/selling signal. The Form 4 was filed the day after the reported transaction.
Insider Transaction Report
- Award
Phantom Stock (unitized)
[F1][F2]2026-04-09$13.63/sh+127.53$1,738→ 410,769.153 total(indirect: By Deferred Compensation Plan)→ Common Stock (36 underlying)
Footnotes (2)
- [F1]Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.
- [F2]Includes phantom stock acquired through dividend reinvestment.